Amplia Therapeutics Ltd.ASX: ATX

Amplia Completes Dosing in Phase 1 Clinical Study of AMP945

Apr 15, 2021 at 2:44 AM UTC · Issued by Amplia Therapeutics Ltd.

Amplia Therapeutics Ltd has released a press release.

View Attachment